Ehealth, Inc. · NASDAQ:EHTH
Ehealth — Q3 2022 Earnings Presentation
16 slides from Ehealth's earnings presentation, Nov 7, 2022
Slide 1: Q3 2022 Financial Results Conference Call Slides
Q3 2022 Financial Results Conference Call Slides November 7, 2022
Slide 2: Safe Harbor Statement
Safe Harbor Statement Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in this
Slide 3: Q3 2022 Financial Highlights
Q3 2022 Financial Highlights Q3 2022 results reflect the Total revenue was $53.4MM, down Net loss narrowed to ($39.1)MM improvements we have 16% year-over-year; Medicare and adjusted EBITDA(1) was made to our sales and revenue of $45.1MM was down 3% ($33.1)MM in Q3 ‘22, compared to marketing operati
Slide 4: eHealth MA Membership
eHealth MA Membership 250,000 700,000 Q3 2022 estimated 600,000 ending (paying) MA 200,000 membership increased by 4% year-over-year. Approved\New Paying Members 500,000 Estimated Membership 150,000 400,000 300,000 100,000 200,000 50,000 100,000 - - Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1
Slide 5: Q3 2022 Total Revenue
Q3 2022 Total Revenue Total Revenue Total revenue declined 16% on a year-over-year basis due primarily to lower positive tail revenue Total Revenue ($MM) within our IFP/SMB business line. $ 63.9 (16%) Q3 2022 results benefited from positive tail $ 53.4 revenue recognized in the quarter. Total positi
Slide 6: Net Loss and Adj. EBITDA
Q3 2022 Net Loss and Adj. EBITDA(1) Net Loss Adjusted EBITDA Net Loss ($MM) Adjusted EBITDA ($MM) ($33.1) ($39.1) 26% 40% ($53.0) ($55.2) Q3-21 Q3-22 Q3-21 Q3-22 (1) Adjusted EBITDA is calculated by excluding the paid-in-kind dividends and change in preferred stock redemption value (together “impact
Slide 7: Major Medicare Online Assisted and Unassisted Applications
Q3 2022 Major Medicare(1) Online Assisted and Unassisted Applications Online business Major Medicare Online Assisted and Unassisted Submissions continues to generate enrollment growth Major Medicare Online Unassisted Major Medicare Online Assisted despite the reduction in Submissions Submissions var
Slide 8: Medicare Segment Revenue and Loss
Q3 2022 Medicare Segment Revenue and Loss Medicare Segment revenue declined slightly Medicare Segment Revenue Medicare Segment Loss (1) due to a reduction in Medicare Segment Revenue ($MM) Medicare Segment Loss ($MM) approved members for Medicare Supplement and Medicare Part D products. $46.4 (3%) $
Slide 9: IFP/SMB Segment Revenue and Profit
Q3 2022 IFP/SMB Segment Revenue and Profit IFP/SMB Segment Revenue and Profit IFP/SMB Segment Revenue IFP/SMB Segment Profit (1) declined compared to Individual, Family, and Small Business Segment Individual, Family, and Small Business Segment Q3 2021 due primarily Revenue ($MM) Profit ($MM) to lowe
Slide 10: TTM Medicare Segment Commissions Cash Collections
Trailing Twelve Months (“TTM”) Medicare Segment Commissions Cash Collections TTM Medicare Segment Commissions Cash Collections Q3 2022 TTM Medicare Segment commissions ($MM) cash collections $350 70% increased by 1% year- over-year. $300 60% +50% +49% +48% $250 +47% 50% +45% +44% +46% +41% +39% +39%
Slide 11: Medicare Advantage Plan Member Turnover Trend Since Q1 2020
Medicare Advantage Plan Member Turnover Trend Since Q1 2020 MA Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Approved Members(1) 64,898 60,477 44,999 217,278 106,884 78,569 36,836 177,469 82,431 51,506 37,777 Estimated Beginning (Paying) Membership(2) 404,694 384,513 407,243 421,
Slide 12: 2022 Operational Priorities
2022 Operational Priorities Through transformative changes, reduce our cost structure while focusing on operational efficiency and excellence; we 1 expect to return to revenue growth in ‘23 on a substantially improved cost and operational foundation. Deploy marketing dollars in a way that will drive
Slide 13: 2022 Guidance
2022 Guidance For the full year ending December 31, 2022, we are reaffirming the following guidance ranges: 2022 Full Year Guidance Range (in millions) Total Revenue $375 – $395 GAAP Net Loss $115 – $92 Adjusted EBITDA(1) ($73) – ($45) Total cash outflow, excluding the impact of our $70 million term
Slide 14: Appendix
Appendix eHealth’
Slide 15: Net Loss to Adjusted EBITDA Reconciliation
Net Loss to Adjusted EBITDA Reconciliation The image part with relationship ID rId17 was not found in the file. 14
Slide 16: FY 2022 Guidance Net Loss to Adjusted EBITDA Reconciliation
FY 2022 Guidance Net Loss to Adjusted EBITDA Reconciliation The image part with relationship ID rId17 was not found in the file. 15